Ziwen Zhao

Dr. Ziwen Zhao

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
LHLing Hao
Ling Hao
XYXiao Yang
Xiao Yang
HCHuiling Chen
Huiling Chen
SWShuquan Wei
Shuquan Wei
BXBanglao Xu
Banglao Xu
ZZZiwen Zhao
Ziwen Zhao
Since COVID-19 might have a lasting impact on global public health, it is crucial to analyze its effect on drug-resistant bacterial infections in the respiratory system for the prevention and control of hospital infections. This work aimed to investigate the impact of the COVID-19 outbreak on the clinical distribution and antibiotic resistance of bacterial infection among hospitalized patients in the respiratory unit in order to establish strategies to control antibiotic-resistant infections. Electronic clinical data registry records from 2018 to 2022 were retrospectively analyzed. A total of 36,829 clinical specimens, including sputum, bronchoalveolar lavage fluid, blood, and urine, were collected from 16,073 patients admitted to the Guangzhou First People’s Hospital from January 2018 to December 2022. Among them, 2209 samples were culture-positive. The bacterial isolation rates of different types of samples showed a similar trend from 2019 to 2022, with an increase in 2020 and 2022 and a decrease in 2021. Different bacterial species were separated from different types of samples. The most reported pathogens were identified in sputum samples. Gram-positive isolates were prevalent in urine samples, while Gram-negative bacilli were the predominant pathogenic bacteria isolated from respiratory tract and blood samples. Pseudomonas aeruginosa (P. aeruginosa), Acinetobacter baumannii (A. baumannii) complex, and Klebsiella pneumoniae (K. pneumoniae) were the most abundant Gram-negative bacteria in sputum samples, of which A. baumannii complex had the highest resistance to all tested antibiotics except colistin. Notably, there has been a substantial prevalence of carbapenem-resistant P. aeruginosa, A. baumannii, and K. pneumoniae in the past five years. This alarming situation calls for greater attention and precaution with prescribed antibiotics to limit the generation and spread of new multidrug-resistant bacteria and improve therapeutic management.

27 June 2021 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
YLYujun Li
Yujun Li
ZLZhike Liang
Zhike Liang
HHHua He
Hua He
XHXiaomei Huang
Xiaomei Huang
ZMZexun Mo
Zexun Mo
SWShuquan Wei
Shuquan Wei
Long non‐coding ribonucleic acids (lncRNAs) play critical roles in acute lung injury (ALI). We aimed to explore the involvement of lncRNA HOX transcript antisense intergenic ribonucleic acid (HOTAIR) in regulating autophagy in lipopolysaccharide (LPS)‐induced ALI. We obtained 1289 differentially expressed lncRNAs or messenger RNAs (mRNAs) via microarray analysis. HOTAIR was significantly upregulated in the LPS stimulation experimental group. HOTAIR knockdown (si‐HOTAIR) promoted cell proliferation in LPS‐stimulated A549 and BEAS‐2B cells, suppressing the protein expression of autophagy marker light chain 3B and Beclin‐1. Inhibition of HOTAIR suppressed LPS‐induced cell autophagy, apoptosis and arrested cells in the G0/G1 phase prior to S phase entry. Further, si‐HOTAIR alleviated LPS‐induced lung injury in vivo. We predicted the micro‐ribonucleic acid miR‐17‐5p to target HOTAIR and confirmed this via RNA pull‐down and dual luciferase reporter assays. miR‐17‐5p inhibitor treatment reversed the HOTAIR‐mediated effects on autophagy, apoptosis, cell proliferation and cell cycle. Finally, we predicted autophagy‐related genes (ATGs) ATG2, ATG7 and ATG16 as targets of miR‐17‐5p, which reversed their HOTAIR‐mediated protein upregulation in LPS‐stimulated A549 and BEAS‐2B cells. Taken together, our results indicate that HOTAIR regulated apoptosis, the cell cycle, proliferation and autophagy through the miR‐17‐5p/ATG2/ATG7/ATG16 axis, thus driving LPS‐induced ALI.

30 September 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
LHLing Hao
Ling Hao
XYXiao Yang
Xiao Yang
HCHuiling Chen
Huiling Chen
MMMo Mo
Mo Mo
YLYujun Li
Yujun Li
ZZZiwen Zhao
Ziwen Zhao
Carbapenem-resistant Klebsiella pneumoniae (CRKP) are usually multidrug resistant (MDR) and cause serious therapeutic problems. Colistin is a critical last-resort therapeutic option for MDR bacterial infections. However, increasing colistin use has led to the emergence of extensively drug-resistant (XDR) strains, raising a significant challenge for healthcare. In order to gain insight into the antibiotic resistance mechanisms of CRKP and identify potential drug targets, we compared the molecular characteristics and the proteomes among drug-sensitive (DS), MDR, and XDR K. pneumoniae strains. All drug-resistant isolates belonged to ST11, harboring blaKPC and hypervirulent genes. None of the plasmid-encoded mcr genes were detected in the colistin-resistant XDR strains. Through a tandem mass tag (TMT)-labeled proteomic technique, a total of 3531 proteins were identified in the current study. Compared to the DS strains, there were 247 differentially expressed proteins (DEPs) in the MDR strains and 346 DEPs in the XDR strains, respectively. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis revealed that a majority of the DEPs were involved in various metabolic pathways, which were beneficial to the evolution of drug resistance in K. pneumoniae. In addition, a total of 67 DEPs were identified between the MDR and XDR strains. KEGG enrichment and protein–protein interaction network analysis showed their participation in cationic antimicrobial peptide resistance and two-component systems. In conclusion, our results highlight the emergence of colistin-resistant and hypervirulent CRKP, which is a noticeable superbug. The DEPs identified in our study are of great significance for the exploration of effective control strategies against infections of CRKP.

29 June 2021 in FEBS Open Bio
Verified
Journal Article
Open access
PDF file
GWGuixiong Wu
Guixiong Wu
DZDongfeng Zhai
Dongfeng Zhai
JXJiemei Xie
Jiemei Xie
SZShuiquan Zhu
Shuiquan Zhu
ZLZhuo Liang
Zhuo Liang
ZZZiwen Zhao
Ziwen Zhao
Lung adenocarcinoma (LUAD) accounts for almost 40% of lung cancers, leading to significant associated morbidity and mortality rates. However, the mechanism of LUAD tumorigenesis remains far from clear. Here, we scanned down‐regulated genes involved in LUAD sourced from The Cancer Genome Atlas and Gene Expression Omnibus data and focused on G protein‐coupled receptor 133 (GPR133). We offer compelling evidence that GPR133 was expressed at low levels in the setting of LUAD, and higher expression was positively related to a better prognosis among patients with LUAD. Functionally, GPR133 inhibited cell proliferation and tumor growth in vitro and in vivo. Regarding the mechanism, flow cytometry assays and western blot assays showed that GPR133 enhanced p21 and decreased cyclin B1 expression, thus triggering LUAD cells at G2/M‐phase arrest. Consistent with this, we evaluated the expression levels of cell‐cycle biomarkers and found that bioinformatics analysis combined with N6‐methyladenosine (methylation at the N6 position in adenosine) RNA immunoprecipitation‐qPCR assay indicated that GPR133 expression was down‐regulated by this modification. Moreover, we observed that methyltransferase‐like 3 was impaired in LUAD, and that it is able to significantly increase levels of GPR133 by enhancing its RNA stability. In conclusion, we found that GPR133 expression was down‐regulated in LUAD via N6‐methyladenosine modification. Increasing GPR133 levels could suppress LUAD cell proliferation and tumor growth.

1 January 2026 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
CFChangquan Fang
Changquan Fang
YZYushan Zhang
Yushan Zhang
AZAnbing Zhang
Anbing Zhang
JLJunhong Lin
Junhong Lin
JZJialiu Zou
Jialiu Zou
LXLimin Xu
Limin Xu
Purpose: Chlamydia psittaci pneumonia is an uncommon type of pneumonia characterized by non-specific clinical manifestations. Current knowledge regarding its clinical features is insufficient. Therefore, we aimed to elucidate its epidemiological profile, clinical characteristics, and distinctions between severe and non-severe cases. Patients and Methods: Clinical data of 186 patients diagnosed with C. psittaci pneumonia using next-generation sequencing (NGS) were systematically collected from seven hospitals in Guangdong Province, China, between January 2019 and June 2025. Epidemiological characteristics, clinical presentations, laboratory results, chest computed tomography (CT) features, bronchoscopy findings, and treatment outcomes were analyzed, with comparisons by disease severity. Results: Of 186 patients (58.1% male, 50– 74 years), 43.5% presented with severe disease, and 67.2% developed complications. Most cases occurred during autumn or winter (67.2%), and a history of bird or poultry exposure was reported in 68.3%. Prevalent clinical symptoms included fatigue (98.9%), high fever (90.3%), and headache (73.7%). Laboratory findings showed elevated serum levels of C-reactive protein, procalcitonin, fibrinogen, and D-dimer in most patients (over 90%). Additionally, over 70% had increased neutrophilia, alanine transaminase, aspartate transaminase, and lactate dehydrogenase levels, with reduced lymphocyte counts. Chest CT findings frequently revealed pulmonary consolidation (100%), ground-glass opacities (97.8%), and air bronchograms (81.2%). Severe cases showed extensive bilateral and multilobar consolidation, with increased prevalence of pleural and pericardial effusions. The median time from admission to diagnosis was 3 (2– 4) days, with 96.2% of patients improving following targeted antimicrobial therapy and being discharged, while 3.2% died. Conclusion: C. psittaci pneumonia is characterized by a high incidence of severe cases and both intrapulmonary and extrapulmonary complications. Its clinical manifestations are diverse and multifaceted, with hallmark features including high fever, relative bradycardia, normal white blood cell counts, elevated transaminases, and pulmonary consolidation. Early diagnosis through NGS and targeted antimicrobial therapy are associated with positive patient outcomes.

1 June 2025 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
CFChangquan Fang
Changquan Fang
LXLimin Xu
Limin Xu
JLJiancong Lu
Jiancong Lu
YLYujun Li
Yujun Li
ZZZiwen Zhao
Ziwen Zhao
Background: Some patients with Chlamydia psittaci pneumonia exhibit liver function abnormalities. In this study, we aimed to elucidate the characteristics of liver function changes and the factors influencing liver injury in patients with Chlamydia psittaci pneumonia, providing a reference for clinical treatment. Methods: The clinical data of patients with Chlamydia psittaci pneumonia admitted to three tertiary Grade A hospitals in Guangdong Province, China, from January 2020 to February 2025 were retrospectively collected. Changes in liver parameters and related influencing factors upon admission were analyzed. Results: Overall, 120 cases were included: 100 (83.3%) exhibited liver function abnormalities and 55 (45.8%) had liver injury. The incidence of liver function abnormalities and liver injury was significantly higher in the severe group than that in the mild group. Liver function abnormalities and injury associated with Chlamydia psittaci pneumonia were characterized by elevations in alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyltransferase (GGT) levels. AST and ALT levels exceeded three times the upper limit of normal (ULN) in 43 (35.8%) and 20 (16.7%) cases, respectively, while GGT exceeded twice the ULN in 25 (20.8%) cases. ALT (70 [47– 115] vs 51 [26– 73] U/L, p = 0.002) and AST (122 [72– 252] vs 52 [30– 76] U/L, p = 0.000) were significantly different between the severe and mild groups. Hepatocellular injury was the most common type of liver injury upon admission, followed by mixed and cholestatic types. Compared to patients without liver injury, those with liver injury had a higher prevalence of alcohol consumption history, dyspnea, higher pneumonia severity index scores, and longer hospital stays. Conclusion: Patients with Chlamydia psittaci pneumonia, particularly severe cases, are prone to concurrent liver function abnormalities and liver injury. Liver injury, predominantly hepatocellular injury, was associated with factors such as alcohol consumption history, pneumonia severity, and elevated inflammatory responses, leading to prolonged hospital stays. Monitoring liver function may aid in early identification of severe cases.